Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-23 09:46:36 UTC

$TLX Telix Stock Slumps on SEC Probe Despite Strong Q2 | via

• Shares down as much as XX% after Telix disclosed SEC subpoena tied to disclosures on prostate cancer drugs.
• Q2 revenue surged 63%, with 2025 guidance reaffirmed at $770M–$800M.
• Jefferies trimmed PT slightly from A$34.50 to A$34.00, citing lengthy regulatory process.
• Shares -XXXX% pre-market.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947956505908584945/c:line.svg)

**Related Topics**
[$800m](/topic/$800m)
[$770m](/topic/$770m)
[drugs](/topic/drugs)
[stocks](/topic/stocks)
[q2](/topic/q2)
[sec](/topic/sec)
[$tlx](/topic/$tlx)

[Post Link](https://x.com/overnight_stock/status/1947956505908584945)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

overnight_stock Avatar overnightstocks.com @overnight_stock on x XXX followers Created: 2025-07-23 09:46:36 UTC

$TLX Telix Stock Slumps on SEC Probe Despite Strong Q2 | via

• Shares down as much as XX% after Telix disclosed SEC subpoena tied to disclosures on prostate cancer drugs. • Q2 revenue surged 63%, with 2025 guidance reaffirmed at $770M–$800M. • Jefferies trimmed PT slightly from A$34.50 to A$34.00, citing lengthy regulatory process. • Shares -XXXX% pre-market.

XXX engagements

Engagements Line Chart

Related Topics $800m $770m drugs stocks q2 sec $tlx

Post Link

post/tweet::1947956505908584945
/post/tweet::1947956505908584945